Skip to main content
Home > Subscribe > Subscribe Home > BioCentury On BioBusiness

BioCentury, the Bernstein Report on BioBusiness

BioCentury

BioCentury's weekly flagship publication provides analysis, interpretation and commentary on biopharma industry corporate performance, product discovery and development, emerging companies and technologies, regulatory events and innovation, public policy and financial markets.

See a sample Cover Story
See a sample Company Deal Story
See a sample Product Discovery & Development Story
See a sample Ebb & Flow Financial Story
See a sample Emerging Company Profile
See a sample Regulatory Story
See a sample Public Policy Story

A subscription to BioCentury, the Bernstein Report on BioBusiness includes, at no additional cost, these essential value-added components:
 

BioCentury Week in Review
Provides a weekly compendium of biopharma deals, clinical and regulatory events, and financial transactions.

See the BioCentury Week in Review

BioCentury Extra
Published every business day to be viewed on mobile devices or online, providing busy executives and investors with a concise report of key industry news events that are selected for importance by BioCentury's experienced editors.

See the Daily Extra

BioCentury Quarterly Stock Roundup
Tracking more than 500 public biotech companies in the U.S., Europe, Canada and Asia-Pacific, this complete overview records the performance of 44 industry subgroups, the BioCentury 100 Index and other benchmark indices, and each quarter's fundraising activity.


Your subscription includes these special BioCentury editions every year:

The "Buyside View" every January
The "Iceberg Annual Report on European Biotech" every May
The "Back to School Issue" every September
The "Quarterly Stock Review" issued at the end of each quarter